Organovo Announces Fiscal Second-Quarter Results; Company Affirms Full-Year Fiscal 2016 and Long-Range Outlook

Organovo (ONVO) Misses Q2 EPS by 2c

Organovo (NYSE: ONVO) reported Q2 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $301 thousand versus the consensus estimate of $29 thousand.

The Company also achieved its next milestone for its kidney program ahead of schedule.... More